|
Tuesday, 08/03/2010
|
On the Repeated Estimation of Survival Time Quantiles for a Time-to-Event Study in Follow-Up Stage
Sunhee Kwon Ro, Onyx Pharmaceuticals; Yu-Lin Chang, Onyx Pharmaceuticals
|
Application of Bayesian Joint Modeling of Time-to-Event and Patient-Reported Outcomes in an Oncology Clinical Trial
Luping Zhao, Eli Lilly and Company; Wei Shen, Eli Lilly and Company; Haoda Fu, Eli Lilly and Company ; Michelle Denise Hackshaw, Eli Lilly and Company; Mark E. Boye, Eli Lilly and Company
9:15 AM
|
A Frailty-Model-Based Approach to Estimating the Age-Dependent Penetrance Function of a Gene Mutation Using Family-Based Study Designs
Yun-Hee Choi, The University of Western Ontario; Laurent Briollais, Samuel Lunenfeld Research Institute
9:35 AM
|
Asymptotic Properties of Logrank and Stratified Logrank Tests on Highly Stratified Time-to-Event Data
Yabing Mai, Merck Research Laboratories; Sherry Liu, Merck Research Laboratories; Tinghui Yu, Binghamton University
10:50 AM
|
Spatial Time-to-Event Analysis of Air Pollution and Preterm Birth
Howard Chang, Statistical and Applied Mathematical Sciences Institute; Brian Reich, North Carolina State University; Marie Lynn Miranda, Duke University
11:15 AM
|
Sample-Size Calculation for Time-to-Event Outcome with Treatment Lag Effect
Yulei Zhang, Columbia University; Tai-Tsang Chen, Bristol-Myers Squibb/Columbia University
11:20 AM
|
A Novel Rank Rest for a Time-to-Event Outcome That Incorporates Information on a Surrogate Event
Pamela A. Shaw, National Institute of Allergy and Infectious Diseases; Michael P. Fay, National Institute of Allergy and Infectious Diseases
2:05 PM
|
|
Wednesday, 08/04/2010
|
A Comparison of the Results of Intent-to-Treat, per-Protocol, and g-Estimation in the Presence of Nonrandom Treatment Changes in a Time-to-Event Noninferiority Trial
Yutaka Matsuyama, The University of Tokyo
10:55 AM
|
Sensitivity Analyses Adjusting for Early Discontinuation of Study Medication in the RE-LY Trial: An Open-Label, Randomized, Active-Controlled, Time-to-Event Noninferiority Trial
Xiuyu Cong, Boehringer Ingelheim Pharmaceuticals, Inc.; Qiqi Deng, Boehringer Ingelheim Pharmaceuticals, Inc.; Susan Q. Wang, Boehringer Ingelheim Pharmaceuticals, Inc.
11:15 AM
|
A Bayesian Design with the Time-to-Event Endpoint
Qiong Wang, GlaxoSmithKline
11:35 AM
|
Performance Measures for Survival Prediction Models: An Overview
Linda M. Peelen, Julius Center for Health Sciences and Primary Care UMC Utrecht; Nina P. Paynter, Brigham and Women's Hospital; Karel G.M. Moons, Julius Center for Health Sciences and Primary Care UMC Utrecht; Nancy Cook, Brigham and Women's Hospital
2:05 PM
|
Bias in Oncology Time-to-Event Data Analysis
Din Chen, Georgia Southern University; Yuhlong Lio, The University of South Dakota; Yibin Wang, Novartis
2:05 PM
|
Multivariate Modeling of Longitudinal Health Care Costs and Time-to-Event Data in Matched Pairs
An Creemers, Universiteit Hasselt; Marc Aerts, Hasselt University; Niel Hens, Hasselt University; Ziv Shkedy, Universiteit Hasselt; Frank De Smet, National Alliance of Christian Mutualities; Philippe Beutels, Universiteit Antwerpen
2:20 PM
|
Performance of Prediction Measures in a Survival Setting
Nina P. Paynter, Brigham and Women's Hospital; Linda M. Peelen, Julius Center for Health Sciences and Primary Care UMC Utrecht; Nancy Cook, Brigham and Women's Hospital
2:25 PM
|
|